Literature DB >> 10940902

Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development.

C M Banwell1, K M Partington, E J Jenkinson, G Anderson.   

Abstract

T cell precursor development depends upon poorly defined interactions between thymocyte precursors and stromal cells involving cell surface molecules, extracellular matrix (ECM) components and soluble growth factors. To determine whether presentation of soluble factors by ECM is involved in early T cell development, we analyzed expression of ECM components in individual thymic stromal subsets and investigated their ability to present ECM-associated IL-7, a factor known to be important during early thymocyte development. We show that MHC class II(+) thymic epithelium and fibroblasts - essential requirements for development of CD4(-)8(-)precursors - both show surface expression of ECM components such as fibronectin and heparan sulfate. Use of biotinylated IL-7 protein indicates that both cell types bind IL-7, while enzymatic disruption of specific ECM components indicates that IL-7 presentation by both cell types is dependent upon heparan sulfate. However, disruption of IL-7 presentation specifically on fibroblasts does not affect their ability to contribute to T cell development. Collectively, these data suggest that while ECM-mediated presentation of IL-7 may be a general function of thymic stromal cells during thymocyte development, heparan sulfate-mediated IL-7 presentation specifically by fibroblasts is not essential and that the specific requirement for fibroblasts in early development involves additional undefined interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940902     DOI: 10.1002/1521-4141(2000)30:8<2125::AID-IMMU2125>3.0.CO;2-H

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis.

Authors:  Grace Y Kim; Davinna L Ligons; Changwan Hong; Megan A Luckey; Hilary R Keller; Xuguang Tai; Philip J Lucas; Ronald E Gress; Jung-Hyun Park
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  T cell homeostasis requires G protein-coupled receptor-mediated access to trophic signals that promote growth and inhibit chemotaxis.

Authors:  Ryan M Cinalli; Catherine E Herman; Brian O Lew; Heather L Wieman; Craig B Thompson; Jeffrey C Rathmell
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

3.  Immune Modulation by Mesenchymal Stem Cells.

Authors:  Francesco Bifari; Veronica Lisi; Elda Mimiola; Annalisa Pasini; Mauro Krampera
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

4.  Identification of fibroblast progenitors in the developing mouse thymus.

Authors:  Pedro Ferreirinha; Ruben G R Pinheiro; Jonathan J M Landry; Nuno L Alves
Journal:  Development       Date:  2022-05-26       Impact factor: 6.862

5.  Seeing is believing: illuminating the source of in vivo interleukin-7.

Authors:  Grace Yoonhee Kim; Changwan Hong; Jung-Hyun Park
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

6.  Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity.

Authors:  David Anak Simon Davis; Christopher R Parish
Journal:  Front Immunol       Date:  2013-12-18       Impact factor: 7.561

Review 7.  A stromal address code defined by fibroblasts.

Authors:  Greg Parsonage; Andrew D Filer; Oliver Haworth; Gerard B Nash; G Ed Rainger; Michael Salmon; Christopher D Buckley
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

8.  Differential requirement for mesenchyme in the proliferation and maturation of thymic epithelial progenitors.

Authors:  William E Jenkinson; Eric J Jenkinson; Graham Anderson
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

9.  Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation.

Authors:  Linda Kenins; Jason W Gill; Richard L Boyd; Georg A Holländer; Aleksandra Wodnar-Filipowicz
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.